Synbiotic supplementation: effects on faecal microbiota and immunity in physically active individuals.

Not Applicable

Completed

• Conditions: Gastrointestinal illness; Upper respiratory tract illness; Alternative and Complementary Medicine - Other alternative and complementary medicine; Inflammatory and Immune System - Normal development and function of the immune system

• Registration Number: ACTRN12611000807954
• Lead Sponsor: Probiotec Pharma Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-08-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 45

Inclusion Criteria

Undertaking a minimum 3 exercise sessions per week, have a minimum VO2max (maximum oxygen uptake) of 45ml/kg/min and not have taken antibiotics for a period of one month before the start of supplementation.

Exclusion Criteria

Individuals outside of the age or VO2max range, taking immunomodulating medications, asthmatics and individuals with irritable bowel symptoms.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Faecal recovery of Lactobacillus rhamnosus measured via denaturing gradient gel electrophoresis and quantitative polymerase chain reaction.[Pre and post supplementation];Recovery of faecal lactobacillus paracasei measured denaturing gradient gel electrophoresis and quantitative polymerase chain reaction.[pre supplementation and post supplementation.]